DexCom, Inc. (DXCM)

DexCom Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	4,662	4,033	3,622	2,910	2,449
Revenue Growth (YoY)	15.60%	11.34%	24.49%	18.84%	27.08%
Cost of Revenue	1,860	1,595	1,333	1,027	768
Gross Profit	2,802	2,438	2,289	1,883	1,681
Selling, General & Admin	1,291	1,286	1,185	1,008	810.5
Research & Development	599.1	552.4	505.8	484.2	604.2
Total Operating Expenses	1,890	1,838	1,691	1,492	1,415
Operating Income	911.8	600	597.7	391.2	265.8
Other Non-Operating Income (Expense)	176.6	109	112.7	-0.4	-9
Total Non-Operating Income (Expense)	176.6	109	112.7	-0.4	-9
Pretax Income	1,088	709	710.4	390.8	256.8
Provision for Income Taxes	252.1	132.8	168.9	49.6	39.9
Net Income	836.3	576.2	541.5	341.2	216.9
Net Income to Common	836.3	576.2	541.5	341.2	216.9
Net Income Growth	45.14%	6.41%	58.70%	57.31%	-60.54%
Shares Outstanding (Basic)	390	394	386	389	387
Shares Outstanding (Diluted)	406	413	426	428	429
Shares Change (YoY)	-1.75%	-3.01%	-0.47%	-0.30%	2.00%
EPS (Basic)	2.14	1.46	1.40	0.88	0.56
EPS (Diluted)	2.09	1.42	1.30	0.82	0.53
EPS Growth	47.18%	9.23%	58.54%	54.72%	-60.15%
Shares Outstanding	384.8	390.7	385.4	386.3	384.6
Free Cash Flow	1,077	630.7	511.9	304.7	53.3
Free Cash Flow Growth	70.79%	23.21%	68.00%	471.67%	-80.73%
Free Cash Flow Per Share	2.66	1.53	1.20	0.71	0.12
Gross Margin	60.10%	60.46%	63.19%	64.72%	68.63%
Operating Margin	19.56%	14.88%	16.50%	13.44%	10.86%
Profit Margin	17.94%	14.29%	14.95%	11.73%	8.86%
FCF Margin	23.11%	15.64%	14.13%	10.47%	2.18%
EBITDA	1,164	817.7	783.7	547.1	367.8
EBITDA Margin	24.96%	20.28%	21.64%	18.80%	15.02%
EBIT	911.8	600	597.7	391.2	265.8
EBIT Margin	19.56%	14.88%	16.50%	13.44%	10.86%
Effective Tax Rate	23.16%	18.73%	23.78%	12.69%	15.54%

Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q